Nanomedicine Has Potential

“Their study is the first to demonstrate an intravenous medication that can cross the blood-brain barrier. The discovery may one day lead to new clinical therapies for treating glioblastoma, and could lead to further therapies adopting their method for other “undruggable” tumors.”

Read more about how nanomedicine could be a potential treatment/cure for GBMs.

Lenox Hill

Check out the new series on Netflix called Lenox Hill. The series follows the incredible neurosurgeons at Lenox Hill Hospital as they help patients with GBMs.

Positive Results with Cannabidiol Treatment

Research shows the benefits of using cannabidiol (a non-psychoactive component of cannabis) in the treatment of glioblastoma:

… The control group received temozolomide (chemotherapy) only and had a 44% 1-year survival rate. In contrast, the cannabidiol combination plus temozolomide group showed a 83% 1-year survival rate with a median survival over 662 days compared with 369 days in the control group…

Read the full article: Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs.

Another article can be found here: The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids

Rise in GBM Incidence in England

This new study found a significant increase in the incidence of GBM in England from 1995-2015. The conclusion suggests that “environmental or lifestyle factors may be responsible.” Read the full article from the Journal of Environmental and Public Health here.

Here’s are some tips from the Environmental Health trust to be safer with your technology usage: 10 Steps To Safer Technology At Home: How To Reduce Exposure To Wireless Radiation

Immune Cells Could Fight Brain Tumors

“Glioblastoma brain tumors can have an unusual effect on the body’s immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body’s defenses.

Where the T-cells go has been unclear, even as immunotherapies are increasingly employed to stimulate the body’s natural ability to fight invasive tumors.

Now researchers at Duke Cancer Institute have tracked the missing T-cells in glioblastoma patients. They found them in abundance in the bone marrow…”

Read more from Duke Health.